A cohort study for patients with Gestational Trophoblastic Neoplasia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a comprehensive cohort of patients diagnosed with Gestational Trophoblastic Neoplasia (GTN) by collecting data from both retrospective and prospective cases across multiple tertiary hospitals. It will establish standardized criteria for patient inclusion and exclusion, gather baseline information such as age, reproductive history, and genetic data, and collect biological specimens. Additionally, the study will monitor patients' treatment plans, hCG levels, side effects, and follow-up outcomes including fertility status and recurrence rates.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ① Age ≥ 18 years old; ② Patients clinically diagnosed with GTN (including invasive cases) Molar pregnancy, choriocarcinoma, PSTT, ETT); ③ Complete informed consent for enrollment.

Exclusion Criteria:

* ① Having mental illness or cognitive impairment, unable to cooperate in completing the investigation with Patients with concurrent malignant tumors; ③ Participants with severe missing follow-up data.

Where it's running

• Weiguo Lv
  Zhengjiang, Hangzhou, China Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exploring the psychological effects of GTN treatment on women

  This study is trying to understand how women feel emotionally after finishing treatment for Gestational Trophoblastic Neoplasia and what kind of support they have received.

  Recruiting Sheffield Teaching Hospitals NHS Foundation Trust · Sheffield, South Yorkshire · NCT06169644

• Combination treatment of toripalimab and actinomycin-D for gestational trophoblastic neoplasia

  This study is testing if combining two drugs, toripalimab and actinomycin-D, can help people with gestational trophoblastic neoplasia respond better than just using actinomycin-D alone.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT06028672

• Using toripalimab and actinomycin-D to treat gestational trophoblastic neoplasia

  This study is testing if a new combination of toripalimab and actinomycin-D can effectively treat gestational trophoblastic neoplasia in patients with a specific score, to see if it works better than standard chemotherapy.

  Recruiting Phase 2 Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT06020755

• Camrelizumab plus apatinib for high‑risk gestational trophoblastic neoplasia

  This trial will test whether adding camrelizumab and apatinib to chemotherapy helps women with ultra high‑risk or chemo‑refractory/relapsed high‑risk gestational trophoblastic neoplasia achieve remission.

  Recruiting Phase 2 Peking Union Medical College Hospital · Beijing · NCT05139095

• Treatment options for hydatidiform mole with lung nodules

  This study is testing different treatment options for patients with hydatidiform mole and lung nodules to see which approach works best for getting their hormone levels back to normal.

  Recruiting Women's Hospital School Of Medicine Zhejiang University · Hangzhou, Zhejiang · NCT03785574

• Hysteroscopic Repeat Curettage as First-Line Treatment for Low-Risk Postmolar GTN

  This study tests whether hysteroscopic repeat curettage can be a first-line option for low-risk postmolar GTN, compared with methotrexate chemotherapy.

  Recruiting Phase 2 Women's Hospital School Of Medicine Zhejiang University · Hangzhou, Zhejiang · NCT03703271

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.